REQUEST A DEMO
Total
USD $0.00
Search more companies

Biodrug S. R. O. (Slovakia)

Main Activities: Research and Development in the Social Sciences and Humanities | Marketing Research and Public Opinion Polling
Full name: Biodrug S. R. O. Profile Updated: July 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Biodrug S. R. O. is an enterprise based in Slovakia. Its main office is in Bratislava. It operates in the Research and Development in the Social Sciences and Humanities industry. It was first established on November 14, 2014. It currently has a total number of 5 - 9 (2025) employees. There was a net sales revenue increase of 15.25% reported in Biodrug S. R. O.’s latest financial highlights for 2024. During that time, Biodrug S. R. O.’s total assets grew by 29.33%. The net profit margin of Biodrug S. R. O. decreased by 0.52% in 2024.

Headquarters
Bozeny Nemcovej, 8
Bratislava; Bratislavsky; Postal Code: 81104

Contact Details: Purchase the Biodrug S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Biodrug S. R. O. report to view the information.
Registered Capital:
Purchase the Biodrug S. R. O. report to view the information.
Financial Auditors:
Purchase the Biodrug S. R. O. report to view the information.
Incorporation Date:
November 14, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Biodrug S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
15.25%
Total operating revenue
15.26%
Operating profit (EBIT)
27.42%
EBITDA
27.04%
Net Profit (Loss) for the Period
5.06%
Total Assets
29.33%
Total Equity
59.32%
Operating Profit Margin (ROS)
0.87%
Net Profit Margin
-0.52%
Return on Equity (ROE)
-10.41%
Debt/Equity
-0.08%
Quick Ratio
-0.59%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?